Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hiromi Sanai
Remarkable Response of Recurrent Endometrial Adenocarcinoma to Daily Oral Administration of Half-Dose Etoposide
SAGE Open Medical Case Reports
Related publications
Intracavitary Chemotherapy (Gliadel®) and Oral Low-Dose Etoposide for Recurrent Anaplastic Ependymoma
Oncology Reports
Medicine
Cancer Research
Oncology
Remarkable Response in a Case of Recurrent Gastrointestinal Stromal Tumor Treated With Low Dose Imatinib
Journal of Nihon University Medical Association
Remarkable Regression of Massive Deep Vein Thrombosis in Response to Intensive Oral Rivaroxaban Treatment
Thrombosis Journal
Hematology
Prevention of Recurrent Endometrial Pathology
Medical Council
Oral High-Dose Ankaferd Administration Effects on Gastrointestinal System
International Journal of Medical Sciences
Medicine
Inhibition of Tumor Angiogenesis by Oral Etoposide
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Response to Daily
Journal of Medical Ethics
Arts
Humanities
Legal Aspects
Health Policy
Health
Ethics
Issues
Examination on Initial Dose in Introduction of Amiodarone Oral Administration. Trial of Initial Dose 800mg/Day.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
An Exceptionally Favorable Response to Etoposide and Cisplatin
Cureus